Goodrx Stock Looks Good After Earnings Beat: Here's What You Need to Know

Goodrx Holdings Inc GDRX shares are trading higher in Tuesday's after-hours session following the company's fourth quarter earnings report. Here's what investors need to know.

By the numbers: Goodrx reported fourth-quarter earnings per share of 7 cents, ahead of the estimate by 5 cents, on revenue of $184.11 million, topping consensus estimate of $178.5 million, according to Benzinga Pro.

• Goodrx reported meeting the needs of over 7 million people, reflecting an 8% decline in monthly active users.

• The company expects first-quarter revenue to be between $181 million and $183 million, well ahead of consensus estimates of $181.72 million.

• Annual revenue is between $780 million and $790 million, ahead of estimates of $778.01 million.

"We continue to focus on efficient profitability growth, steadily improving margins and strong cash conversion," CEO Karsten Voermann said in a statement.

"We believe our balance sheet maintains a strong cash and liquidity position, providing financial flexibility and assisting our capital allocation priorities to support our realigned organization to drive highly efficient and profitable."

GDRX Price Action: Goodrx shares are trading up 6.81% at $5.65, according to Benzinga Pro.

Read next: Mark Cuban says Americans shouldn't have to choose between rent, food or medicine

Photo: NYC Russ via Shutterstock

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.